Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Trypanosoma cruzi (T. cruzi) infection is endemic in Latin America and is becoming a
worldwide health burden. It may lead to heterogeneous phenotypes. Early diagnosis of T …

Esta atualização da Diretriz de Insuficiência Cardíaca Crônica (IC)-2012 surge para
reavaliar as recomendações através de uma avaliação criteriosa das pesquisas …

O objetivo desta Diretriz é servir de apoio e auxiliar os médicos nas decisões referentes aos
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …

The purpose of this paper is to identify research needs for all aspects of the research-to-
decision making pathway that will help us understand and mitigate the health effects of …

Heart failure (HF) data in Latin America (LA) were reviewed to guide health service planning
in the prevention and treatment of HF. The HF epidemiology and the adequacy of relevant …

Background There are few data on heart failure (HF) patients from Africa, Asia, the Middle
East and South America. Methods INTER-CHF is a prospective study that enrolled HF …

Continued assessment of temporal trends in mortality and epidemiology of specific heart
failure in South America is needed to provide a scientific basis for rational allocation of the …

Background/methods Chagas disease is caused by an intracellular parasite, Trypanosoma
cruzi, and it is a leading cause of heart failure in Latin America. The main clinical …

Background—Peculiar aspects of Chagas cardiomyopathy raise concerns about efficacy
and safety of sympathetic blockade. We studied the influence of β-blockers in patients with …